Scottish guidance recommends pregnant women should receive CGM
All pregnant women with type 1 diabetes in Scotland should be offered a continuous glucose monitor (CGM) device, new guidance for the country has recommended.
Although the use of CGM has been supported by the Scottish Government since 2017, it is estimated that only 5-10% of pregnant women with type 1 diabetes in Scotland currently use the devices.
It is expected that this new advice, based upon the most up-to-date evidence, will increase the uptake within NHS boards in Scotland, and encourage more pregnant women to embrace the technology.
Iain Robertson, Chair of the Scottish Health Technologies Group, part of Healthcare Improvement Scotland, said: “We know that the number of pregnant women with type 1 diabetes is gradually rising, so it’s important that we provide them with the best support available to ensure that they stay safe throughout their pregnancy. We would encourage all pregnant women with type 1 diabetes to consider the clear health benefits that continuous glucose monitoring devices bring.”
Prof Brian Kennon, Consultant in Diabetes & Endocrinology at Queen Elizabeth University Hospital and Chair of the Scottish Diabetes Group, added: “We are delighted that the positive findings provide further support for the use of CGM in pregnant woman with type 1 diabetes. This is good news for pregnant women with type 1 diabetes as it will help with access to technologies which have been shown to improve the outcomes for them and their babies.
“Timely access to technologies and improving the care and outcomes of type 1 diabetes and pregnancy are key priority areas within Scotland’s Diabetes Improvement Plan.”
To read the full advice and a plain language summary, click here.